Aurora Cannabis (ACB) vs Citius Oncology (CTOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Citius Oncology (CTOR) over the past year, losing 27.4% versus a loss of 54.6%. Aurora Cannabis is the larger company by market cap ($280.5 million vs $88.3 million), about 3.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | CTOR |
|---|---|---|
| Share price | $4.43 | $0.835 |
| Market cap | $280.46M | $88.31M |
| 1-day change | -0.67% | -2.45% |
| YTD return | +4.98% | -16.50% |
| 1-year return | -27.38% | -54.62% |
| 5-year return | -93.70% | — |
| EPS (TTM) | $-0.61 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $2.25 |
| 52-week low | $2.56 | $0.491 |
| Distance from 52-week high | -33.53% | -62.89% |
| Analyst consensus | buy | none |
| Avg. price target upside | — | +379.04% |
| Average volume | 1.36M | 99.72K |
| Shares outstanding | 63.31M | 105.76M |
| Employees | 1,028 | — |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aurora Cannabis is about 3.2 times larger than Citius Oncology by market value ($280.46M vs $88.31M).
- ACB has outperformed CTOR by 27.2 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Healthcare · Drug Manufacturers - Specialty & Generic
ACB vs CTOR FAQ
Which is bigger, Aurora Cannabis or Citius Oncology?
Aurora Cannabis (ACB) is larger, with a market capitalization of $280.46M compared with $88.31M for Citius Oncology (CTOR).
Which stock has performed better over the past year, ACB or CTOR?
ACB returned -27.38% over the past 12 months, compared with -54.62% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Citius Oncology in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.